Clinical Trial

Effect of The Substitution of Animal Protein by Soya-Based Fermented Product on Human Gut Microbiome

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 24, 2024 (before its estimated October 11, 2024 completion). Its status may not reflect the trial's current state.
Summary
There is a growing understanding of the functioning and interconnectedness of microbiomes in the food system which offers great potential for enabling the development of new solutions contributing to achieving important food and nutrition goals including those requested by FOOD 2030. Of relevance in this regard is the provision of sustainable and healthy protein sources. Because of the obvious environmental and climate concerns associated with the production of animal-derived protein, a transition is needed to healthier and more environment-friendly diets, including a moderate-level consumption of red and processed meat and greater emphasis on plant-based foods. As well as impact of meat production on the climate, it is well established that eating a diet rich in red meat promotes the growth of gut microbiome members that drive or exacerbate inflammation. Plant protein does not have these associations, and in fact it is often accompanied by fibre ingestion, which favours growth of health-promoting gut microbes. Replacing meat with plant protein offers the prospect of improving consumer health by improving the gut microbiome. The EU funded project MICROBIOMES4SOY will assess the effect of replacing animal protein with soya-derived protein on the human gut microbiome and whether this replacement can reduce the risk of inflammation-related diseases by gut microbiome modulation. This knowledge will provide a baseline for establishing new dietary pathways making use of soya protein and support dietary transition for EU citizens.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-03-04; most recent amendment 2024-09-20.
Status change: Not Yet Recruiting → Active, Not Recruiting 2024-09-20
Trial Details
NCT Number NCT06304480
Lead Sponsor University College Cork
Collaborators: AIT Austrian Institute of Technology GmbH
Conditions Gut Microbiome
Enrollment 50 participants
Start Date 2024-06-17
Primary Completion 2024-10-11 (estimated)
Study Completion 2024-10-18 (estimated)
Updated on ClinicalTrials.gov 2024-09-24